How do we approach thrombocytopenia in critically ill patients?

British Journal of Haematology

Volumn 177, Issue 1, 2017, Pages 27-38

  Thachil, Jecko ^a   Warkentin, Theodore E ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

anticoagulation; critical care; platelet; thrombocytopenia; thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER;

BLEEDING; BONE MARROW DISEASE; CLINICAL PRACTICE; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; HEART ASSIST DEVICE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PROGNOSIS; REVIEW; RISK FACTOR; SEPSIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOSIS; BLOOD CLOTTING; CRITICAL ILLNESS; DISEASE MANAGEMENT;

BIOMARKERS; BLOOD COAGULATION; CRITICAL ILLNESS; DISEASE MANAGEMENT; HUMANS; INCIDENCE; PLATELET COUNT; PROGNOSIS; THROMBOCYTOPENIA;

EID: 85006968373     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14482     Document Type: Review

References (88)

1. Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B. & Esteban, R. (2008) Thrombocytopenia associated with chronic liver disease. Journal of Hepatology, 48, 1000–1007.
2. Akca, S., Haji-Michael, P., de Mendonca, A., Suter, P., Levi, M. & Vincent, J.L. (2002) Time course of platelet counts in critically ill patients. Critical Care Medicine, 30, 753–756.
3. Alhamdi, Y. & Toh, C.H. (2016) The role of extracellular histones in haematological disorders. British Journal of Haematology, 173, 805–811.
4. Alhamdi, Y., Abrams, S.T., Lane, S., Wang, G. & Toh, C.H. (2016) Histone-associated thrombocytopenia in patients who are critically ill. Journal of American Medical Association, 315, 817–819.
5. Arnold, D.M., Nazi, I., Warkentin, T.E., Smith, J.W., Toltl, L.J., George, J.N. & Kelton, J.G. (2013) Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfusion Medicine Reviews, 27, 137–145.
6. Aster, R.H., Curtis, B.R., McFarland, J.G. & Bougie, D.W. (2009) Drug-induced immune thrombocytopenia: pathogenesis, diagnosis and management. Journal of Thrombosis and Haemostasis, 7, 911–918.
7. Baughman, R.P., Lower, E.E., Flessa, H.C. & Tollerud, D.J. (1993) Thrombocytopenia in the intensive care unit. Chest, 104, 1243–1247.
8. Boyle, A.J., Di Gangi, S., Hamid, U.I., Mottram, L.J., McNamee, L., White, G., Cross, L.J., McNamee, J.J., O'Kane, C.M. & McAuley, D.F. (2015) Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Critical Care, 19, 1–8.
9. Cervera, R., Rodríguez-Pintó, I., Colafrancesco, S., Conti, F., Valesini, G., Rosário, C., Agmon-Levin, N., Shoenfeld, Y., Ferrão, C., Faria, R., Vasconcelos, C., Signorelli, F. & Espinosa, G. (2013) 14th International congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome. Autoimmunity Reviews, 13, 699–707.
10. Chen, W., Janz, D.R., Bastarache, J.A., May, A.K., O'Neal, H.R., Bernard, G.R. & Ware, L.B. (2015) Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients. Critical Care Medicine, 43, 801–807.
11. Claus, R.A., Bockmeyer, C.L., Budde, U., Kentouche, K., Sossdorf, M., Hilberg, T., Schneppenheim, R., Reinhart, K., Bauer, M., Brunkhorst, F.M. & Lösche, W. (2009) Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thrombosis and Haemostasis, 101, 239–247.
12. Claushuis, T.A., van Vught, L.A., Scicluna, B.P., Wiewel, M.A., Klein Klouwenberg, P.M., Hoogendijk, A.J., Ong, D.S., Cremer, O.L., Horn, J., Franitza, M., Toliat, M.R., Nürnberg, P., Zwinderman, A.H., Bonten, M.J., Schultz, M.J. & van der Poll, T. (2016) Molecular Diagnosis and Risk Stratification of Sepsis Consortium. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood, 127, 3062–3072.
13. Crowther, M.A., Cook, D.J., Meade, M.O., Griffith, L.E., Guyatt, G.H., Arnold, D.M., Rabbat, C.G., Geerts, W.H. & Warkentin, T.E. (2005) Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Journal of Critical Care, 20, 348–353.
14. De Serres, S.A. & Isenring, P. (2009) Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria. Nephrology Dialysis Transplant, 24, 1048–1050.
15. Eckman, P.M. & John, R. (2012) Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation, 125, 3038–3047.
16. Ferreira, J.A. & Johnson, D.W. (2015) The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients. Renal Failure, 37, 1232–1236.
17. Fuchs, T.A., Bhandari, A.A. & Wagner, D.D. (2011) Histones induce rapid and profound thrombocytopenia in mice. Blood, 118, 3708–3714.
18. Fukushima, H., Nishio, K., Asai, H., Watanabe, T., Seki, T., Matsui, H., Sugimoto, M., Matsumoto, M., Fujimura, Y. & Okuchi, K. (2013) Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis. Shock, 39, 409–414.
19. George, J.N., Raskob, G.E., Shah, S.R., Rizvi, M.A., Hamilton, S.A., Osborne, S. & Vondracek, T. (1998) Drug induced thrombocytopenia: a systematic review of published case reports. Annals of Internal Medicine, 129, 886–890.
20. Goel, R., Ness, P.M., Takemoto, C.M., Krishnamurti, L., King, K.E. & Tobian, A.A. (2015) Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood, 125, 1470–1476.
21. Greinacher, A. & Selleng, K. (2010) Thrombocytopenia in the intensive care unit patient. Hematology American Society Hematology Education Program, 2010, 135–143.
22. Greinacher, A., Farner, B., Kroll, H., Kohlmann, T., Warkentin, T.E. & Eichler, P. (2005) Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thrombosis and Haemostasis, 94, 132–135.
23. Harr, J.N., Moore, E.E., Johnson, J., Chin, T.L., Wohlauer, M.V., Maier, R., Cuschieri, J., Sperry, J., Banerjee, A., Silliman, C.C. & Sauaia, A. (2013) Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients. Critical Care Medicine, 41, 399–404.
24. Hugenholtz, G.G., Porte, R.J. & Lisman, T. (2009) The platelet and platelet function testing in liver disease. Clinics in Liver Disease, 13, 11–20.
25. Hui, P., Cook, D.J., Lim, W., Fraser, G.A. & Arnold, D.M. (2011) The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest, 139, 271–278.
26. Idell, S., Maunder, R., Fein, A.M., Switalska, H.I., Tuszynski, G.P., McLarty, J. & Niewiarowski, S. (1989) Platelet-specific alpha-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome. Chest, 96, 1125–1132.
27. Johansson, D., Shannon, O. & Rasmussen, M. (2011) Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One, 6, e26928.
28. Kaushansky, K. (2009) Determinants of platelet number and regulation of thrombopoiesis. Hematology American Society of Hematology Education Program, 2009, 147–152.
29. Kitchens, C.S. (2004) Thrombocytopenia due to acute venous thromboembolism and its role in expanding the differential diagnosis of heparin-induced thrombocytopenia. American Journal of Hematology, 76, 69–73.
30. Kremer Hovinga, J.A., Zeerleder, S., Kessler, P., Romani de Wit, T., van Mourik, J.A., Hack, C.E., ten Cate, H., Reitsma, P.H., Wuillemin, W.A. & Lämmle, B. (2007) ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. Journal of Thrombosis and Haemostasis, 5, 2284–2290.
31. Kumar, A., Mhaskar, R., Grossman, B.J., Kaufman, R.M., Tobian, A.A., Kleinman, S., Gernsheimer, T., Tinmouth, A.T. & Djulbegovic, B. (2015) AABB Platelet Transfusion Guidelines Panel. Platelet transfusion: a systematic review of the clinical evidence. Transfusion, 55, 1116–2.
32. Larkin, C.M., Santos-Martinez, M.J., Ryan, T. & Radomski, M.W. (2016) Sepsis-associated thrombocytopenia. Thrombosis Research, 141, 11–16.
33. Lasky, L.C., Lin, A., Kahn, R.A. & McCullough, J. (1981) Donor platelet response and product quality assurance in plateletpheresis. Transfusion, 21, 247–260.
34. Levi, M. & Meijers, J.C. (2011) DIC: which laboratory tests are most useful. Blood Reviews, 25, 33–37.
35. Lieberman, L., Bercovitz, R.S., Sholapur, N.S., Heddle, N.M., Stanworth, S.J. & Arnold, D.M. (2014) Platelet transfusions for critically ill patients with thrombocytopenia. Blood, 123, 1146–1155.
36. Liu, S., Shi, W., Liang, X., Su, Y., Liang, Y., Zhang, B., Ye, Z., Xu, L., Xia, Y., He, C., Ma, J., Tao, Y., Ye, H. & Li, H. (2010) Celluloase triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration. Blood Purification, 29, 375–382.
37. Lösche, W., Boettel, J., Kabisch, B., Winning, J., Claus, R.A. & Bauer, M. (2012) Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? Thrombosis, 2012, 720254.
38. Mulder, J., Tan, H.K., Bellomo, R. & Silvester, W. (2003) Platelet loss across the hemofilter during continuous hemofiltration. International Journal of Artificial Organs, 26, 906–912.
39. Murphy, D.A., Hockings, L.E., Andrews, R.K., Aubron, C., Gardiner, E.E., Pellegrino, V.A. & Davis, A.K. (2015) Extracorporeal membrane oxygenation-hemostatic complications. Transfusion Medicine Reviews, 29, 90–101.
40. Nachman, R.L. & Rafii, S. (2008) Platelets, petechiae, and preservation of the vascular wall. New England Journal of Medicine, 359, 1261–1270.
41. Neame, P.B., Kelton, J.G., Walker, I.R., Stewart, I.O., Nossel, H.L. & Hirsh, J. (1980) Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood, 56, 88–92.
42. Nijsten, M.W., ten Duis, H.J., Zijlstra, J.G., Porte, R.J., Zwaveling, J.H., Paling, J.C. & The, T.H. (2000) Blunted rise in platelet count in critically ill patients is associated with worse outcome. Critical Care Medicine, 28, 3843–3846.
43. Nurden, A.T. (2011) Platelets, inflammation and tissue regeneration. Thrombosis and Haemostasis, 105, S13–S33.
44. Ono, T., Mimuro, J., Madoiwa, S., Soejima, K., Kashiwakura, Y., Ishiwata, A., Takano, K., Ohmori, T. & Sakata, Y. (2006) Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood, 107, 528–534.
45. Peerschke, E.I. & Ghebrehiwet, B. (1998) Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology, 199, 239–249.
46. Peerschke, E.I., Andemariam, B., Yin, W. & Bussel, J.B. (2010) Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. British Journal of Haematology, 148, 638–645.
47. Perbet, S., Godet, T., Lebreton, A., Sapin, A.F. & Constantin, J.M. (2015) Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU. Journal of Clinical Monitoring and Computing, 29, 25–28.
48. Polley, M.J. & Nachman, R.L. (1983) Human platelet activation by C3a and C3a des-arg. Journal of Experimental Medicine, 158, 603–615.
49. Priziola, J.L., Smythe, M.A. & Dager, W.E. (2010) Drug-induced thrombocytopenia in critically ill patients. Critical Care Medicine, 38, S145–S154.
50. Reese, J.A., Li, X., Hauben, M., Aster, R.H., Bougie, D.W., Curtis, B.R., George, J.N. & Vesely, S.K. (2010) Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood, 116, 2127–2133.
51. Riddell, D.R. & Owen, J.S. (1999) Nitric oxide and platelet aggregation. Vitamin and Hormone, 57, 25–48.
52. Rondina, M.T., Carlisle, M., Fraughton, T., Brown, S.M., Miller, R.R. 3rd, Harris, E.S., Weyrich, A.S., Zimmerman, G.A., Supiano, M.A. & Grissom, C.K. (2015) Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. The Journals of Gerontology: Biological sciences and Medical sciences, 70, 225–231.
53. Rother, R.P., Bell, L., Hillmen, P. & Gladwin, M.T. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Journal of American Medical Association, 293, 1653–1662.
54. Scully, M. & Goodship, T. (2014) How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. British Journal of Haematology, 164, 759–6.
55. Scully, M., Gates, C. & Neave, L. (2016) How we manage patients with heparin induced thrombocytopenia. British Journal of Haematology, 174, 9–15.
56. Selleng, S., Malowsky, B., Strobel, U., Wessel, A., Ittermann, T., Wollert, H.G., Warkentin, T.E. & Greinacher, A. (2010) Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. Journal of Thrombosis and Haemostasis, 8, 30–36.
57. Siegal, D.M., Cook, R.J. & Warkentin, T.E. (2012) Acute hepatic necrosis and ischemic limb necrosis. New England Journal of Medicine, 367, 879–881.
58. Squizzato, A., Hunt, B.J., Kinasewitz, G.T., Wada, H., ten Cate, H., Thachil, J., Levi, M., Vicente, V., D'Angelo, A. & Di Nisio, M. (2016) Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thrombosis and Haemostasis, 115, 896–904.
59. Stanworth, S.J., Walsh, T.S., Prescott, R.J., Lee, R.J., Watson, D.M. & Wyncoll, D.L.; Intensive Care Study of Coagulopathy Investigators. (2013) Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion, 53, 1050–1058.
60. Stasi, R. & Newland, A.C. (2011) ITP: a historical perspective. British Journal of Haematology, 153, 437–450.
61. Stephan, F., Hollande, J., Richard, O., Cheffi, A., Maier-Redelsperger, M. & Flahault, A. (1999) Thrombocytopenia in a surgical ICU. Chest, 115, 1363–1370.
62. Strauss, R., Wehler, M., Mehler, K., Kreutzer, D., Koebnick, C. & Hahn, E.G. (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Critical Care Medicine, 30, 1765–1771.
63. Thachil, J. (2015) Platelets in inflammatory disorders: a pathophysiological and clinical perspective. Seminars in Thrombosis and Hemostasis, 41, 572–581.
64. Thachil, J. (2016a) Disseminated intravascular coagulation: a practical approach. Anesthesiology, 125, 230–236.
65. Thachil, J. (2016b) Disseminated intravascular coagulation - new pathophysiological concepts and impact on management. Expert Reviews in Hematology, 9, 803–814.
66. Tosetto, A., Balduini, C.L., Cattaneo, M., De Candia, E., Mariani, G., Molinari, A.C., Rossi, E. & Siragusa, S. (2009) Italian Society for Haemostasis and Thrombosis. Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thrombosis Research, 124, e13–e18.
67. Tsai, M.J., Ou, S.M., Shih, C.J., Chao, P.W., Wang, L.F., Shih, Y.N., Li, S.Y., Kuo, S.C., Hsu, Y.T. & Chen, Y.T. (2015) Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study. Intensive Care Medicine, 41, 806–813.
68. Valerio-Rojas, J.C., Jaffer, I.J., Kor, D.J., Gajic, O. & Cartin-Ceba, R. (2013) Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study. Critical Care Research Practice, 2013, 782573.
69. Vanderschueren, S., De Weerdt, A., Malbrain, M., Vankersschaever, D., Frans, E., Wilmer, A. & Bobbaers, H. (2000) Thrombocytopenia and prognosis in intensive care. Critical Care Medicine, 28, 1871–1876.
70. Venkata, C., Kashyap, R., Farmer, J.C. & Afessa, B. (2013) Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. Journal of Intensive Care, 1, 9.
71. Vicks, S.L., Gross, M.L. & Schmitt, G.W. (1983) Massive hemorrhage due to hemodialysis-associated thrombocytopenia. American Journal of Nephrology, 3, 30–33.
72. Von Drygalski, A., Curtis, B.R., Bougie, D.W., McFarland, J.G., Ahl, S., Limbu, I., Baker, K.R. & Aster, R.H. (2007) Vancomycin-induced immune thrombocytopenia. New England Journal of Medicine, 356, 904–910.
73. Warkentin, T.E. (2007) Drug-induced immune-mediated thrombocytopenia—from purpura to thrombosis. New England Journal of Medicine, 356, 891–893.
74. Warkentin, T.E. (2015a) Ischemic limb gangrene with pulses. New England Journal of Medicine, 373, 642–655.
75. Warkentin, T.E. (2015b) Ischemic limb gangrene with pulses [letter]. New England Journal of Medicine, 373, 2386–2388.
76. Warkentin, T.E. (2015c) Heparin-induced thrombocytopenia in critically ill patients. Seminars in Thrombosis and Hemostasis, 41, 49–60.
77. Warkentin, T.E. & Kelton, J.G. (1996) A 14-year study of heparin-induced thrombocytopenia. American Journal of Medicine, 101, 502–507.
78. Warkentin, T.E. & Kelton, J.G. (2001) Temporal aspects of heparin-induced thrombocytopenia. New England Journal of Medicine, 344, 1286–1292.
79. Warkentin, T.E. & Pai, M. (2016) Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis? Journal of Thrombosis and Hemostasis, 14, 231–235.
80. Warkentin, T.E. & Smith, J.W. (1997) The alloimmune thrombocytopenic syndromes. Transfusion Medicine Reviews, 11, 296–307.
81. Warkentin, T.E., Cook, R.J., Sarode, R., Sloane, D.A. & Crowther, M.A. (2015a) Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome. Blood, 126, 486–493.
82. Warkentin, T.E., Safyan, E.L. & Linkins, L.A. (2015b) Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages. New England Journal of Medicine, 372, 492–494.
83. Weyrich, A.S. & Zimmerman, G.A. (2013) Platelets in lung biology. Annual Review of Physiology, 75, 569–591.
84. Winning, J., Neumann, J., Kohl, M., Claus, R.A., Reinhard, K., Bauer, M. & Losche, W. (2010) Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Critical Care Medicine, 38, 32–37.
85. Yadav, H. & Kor, D.J. (2015) Platelets in the pathogenesis of acute respiratory distress syndrome. American Journal of Physiology Lung Cell Molecular Physiology, 309, L915–L923.
86. Yaguchi, A., Lobo, F.L.M., Vincent, J.L. & Pradier, O. (2004) Platelet function in sepsis. Journal of Thrombosis and Hemostasis, 2, 2096–2102.
87. Zarbock, A. & Ley, K. (2009) The role of platelets in acute lung injury (ALI). Frontiers in Biosciences, 14, 150–158.
88. Zeidler, K., Arn, K., Senn, O., Schanz, U. & Stussi, G. (2011) Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion, 51, 2269–2276.